SEATTLE, WA--(Marketwire - February 13, 2008) - Calistoga Pharmaceuticals, Inc., a biopharmaceutical company dedicated to developing innovative medicines for the treatment of cancer and inflammatory diseases, announced today that it has appointed R. Lee Douglas, to its board of directors. Mr. Douglas has over 22 years of successful biotechnology operating and management experience with special emphasis on building and developing companies, including business development, strategic portfolio management, and integration of company mergers and acquisitions.
